aluates Reports

$ 0.0

Automative

Global Opioid Drugs Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-17K6084

Global Opioid Drugs Market Insights Forecast to 2028

BUY CHAPTERS

Global Opioid Drugs Market Research Report 2025

Code: QYRE-Auto-17K6084

Report

July 2025

Pages:79

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Acura Pharmaceuticals

Cipher Pharmaceutical Inc.

Daiichi Sankyo

Johnson & Johnson

Lupin Ltd

Pfizer Inc

Sun Pharmaceuticals

Teva Pharmaceutical Industries Ltd

Johnson & Johnson

Opioid Drugs Market Size

The global market for Opioid Drugs was valued at US$ 11210 million in the year 2024 and is projected to reach a revised size of US$ 16230 million by 2031, growing at a CAGR of 5.5% during the forecast period.

Opioid Drugs Market

Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Opioid Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Opioid Drugs.

The Opioid Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Opioid Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Opioid Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Opioid Drugs Market Report

Report Metric	Details
Report Name	Opioid Drugs Market
Accounted market size in year	US$ 11210 million
Forecasted market size in 2031	US$ 16230 million
CAGR	5.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Buprenorphine Fentanyl Hydrocodone Morphine Oxycodone Tramadol Others
Segment by Application	Anesthesia Pain relief Cough suppression Diarrhea suppression Deaddiction Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Acura Pharmaceuticals, Cipher Pharmaceutical Inc., Daiichi Sankyo, Johnson＆Johnson, Lupin Limited, Pfizer, Sun Pharmaceuticals, Teva Pharmaceutical Industries Ltd.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Opioid Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Opioid Drugs Market growing?

Ans: The Opioid Drugs Market witnessing a CAGR of 5.5% during the forecast period 2025-2031.

What is the Opioid Drugs Market size in 2031?

Ans: The Opioid Drugs Market size in 2031 will be US$ 16230 million.

Who are the main players in the Opioid Drugs Market report?

Ans: The main players in the Opioid Drugs Market are Acura Pharmaceuticals, Cipher Pharmaceutical Inc., Daiichi Sankyo, Johnson＆Johnson, Lupin Limited, Pfizer, Sun Pharmaceuticals, Teva Pharmaceutical Industries Ltd.

What are the Application segmentation covered in the Opioid Drugs Market report?

Ans: The Applications covered in the Opioid Drugs Market report are Anesthesia, Pain relief, Cough suppression, Diarrhea suppression, Deaddiction, Others

What are the Type segmentation covered in the Opioid Drugs Market report?

Ans: The Types covered in the Opioid Drugs Market report are Buprenorphine, Fentanyl, Hydrocodone, Morphine, Oxycodone, Tramadol, Others

Recommended Reports

Pain Relief Markets

Analgesics & Opioids

Abuse & Sleeping Drugs

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Opioid Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Buprenorphine

1.2.3 Fentanyl

1.2.4 Hydrocodone

1.2.5 Morphine

1.2.6 Oxycodone

1.2.7 Tramadol

1.2.8 Others

1.3 Market by Application

1.3.1 Global Opioid Drugs Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Anesthesia

1.3.3 Pain relief

1.3.4 Cough suppression

1.3.5 Diarrhea suppression

1.3.6 Deaddiction

1.3.7 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Opioid Drugs Market Perspective (2020-2031)

2.2 Global Opioid Drugs Growth Trends by Region

2.2.1 Global Opioid Drugs Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Opioid Drugs Historic Market Size by Region (2020-2025)

2.2.3 Opioid Drugs Forecasted Market Size by Region (2026-2031)

2.3 Opioid Drugs Market Dynamics

2.3.1 Opioid Drugs Industry Trends

2.3.2 Opioid Drugs Market Drivers

2.3.3 Opioid Drugs Market Challenges

2.3.4 Opioid Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Opioid Drugs Players by Revenue

3.1.1 Global Top Opioid Drugs Players by Revenue (2020-2025)

3.1.2 Global Opioid Drugs Revenue Market Share by Players (2020-2025)

3.2 Global Opioid Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Opioid Drugs Revenue

3.4 Global Opioid Drugs Market Concentration Ratio

3.4.1 Global Opioid Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Opioid Drugs Revenue in 2024

3.5 Global Key Players of Opioid Drugs Head office and Area Served

3.6 Global Key Players of Opioid Drugs, Product and Application

3.7 Global Key Players of Opioid Drugs, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Opioid Drugs Breakdown Data by Type

4.1 Global Opioid Drugs Historic Market Size by Type (2020-2025)

4.2 Global Opioid Drugs Forecasted Market Size by Type (2026-2031)

5 Opioid Drugs Breakdown Data by Application

5.1 Global Opioid Drugs Historic Market Size by Application (2020-2025)

5.2 Global Opioid Drugs Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Opioid Drugs Market Size (2020-2031)

6.2 North America Opioid Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Opioid Drugs Market Size by Country (2020-2025)

6.4 North America Opioid Drugs Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Opioid Drugs Market Size (2020-2031)

7.2 Europe Opioid Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Opioid Drugs Market Size by Country (2020-2025)

7.4 Europe Opioid Drugs Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Opioid Drugs Market Size (2020-2031)

8.2 Asia-Pacific Opioid Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Opioid Drugs Market Size by Region (2020-2025)

8.4 Asia-Pacific Opioid Drugs Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Opioid Drugs Market Size (2020-2031)

9.2 Latin America Opioid Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Opioid Drugs Market Size by Country (2020-2025)

9.4 Latin America Opioid Drugs Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Opioid Drugs Market Size (2020-2031)

10.2 Middle East & Africa Opioid Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Opioid Drugs Market Size by Country (2020-2025)

10.4 Middle East & Africa Opioid Drugs Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Acura Pharmaceuticals

11.1.1 Acura Pharmaceuticals Company Details

11.1.2 Acura Pharmaceuticals Business Overview

11.1.3 Acura Pharmaceuticals Opioid Drugs Introduction

11.1.4 Acura Pharmaceuticals Revenue in Opioid Drugs Business (2020-2025)

11.1.5 Acura Pharmaceuticals Recent Development

11.2 Cipher Pharmaceutical Inc.

11.2.1 Cipher Pharmaceutical Inc. Company Details

11.2.2 Cipher Pharmaceutical Inc. Business Overview

11.2.3 Cipher Pharmaceutical Inc. Opioid Drugs Introduction

11.2.4 Cipher Pharmaceutical Inc. Revenue in Opioid Drugs Business (2020-2025)

11.2.5 Cipher Pharmaceutical Inc. Recent Development

11.3 Daiichi Sankyo

11.3.1 Daiichi Sankyo Company Details

11.3.2 Daiichi Sankyo Business Overview

11.3.3 Daiichi Sankyo Opioid Drugs Introduction

11.3.4 Daiichi Sankyo Revenue in Opioid Drugs Business (2020-2025)

11.3.5 Daiichi Sankyo Recent Development

11.4 Johnson＆Johnson

11.4.1 Johnson＆Johnson Company Details

11.4.2 Johnson＆Johnson Business Overview

11.4.3 Johnson＆Johnson Opioid Drugs Introduction

11.4.4 Johnson＆Johnson Revenue in Opioid Drugs Business (2020-2025)

11.4.5 Johnson＆Johnson Recent Development

11.5 Lupin Limited

11.5.1 Lupin Limited Company Details

11.5.2 Lupin Limited Business Overview

11.5.3 Lupin Limited Opioid Drugs Introduction

11.5.4 Lupin Limited Revenue in Opioid Drugs Business (2020-2025)

11.5.5 Lupin Limited Recent Development

11.6 Pfizer

11.6.1 Pfizer Company Details

11.6.2 Pfizer Business Overview

11.6.3 Pfizer Opioid Drugs Introduction

11.6.4 Pfizer Revenue in Opioid Drugs Business (2020-2025)

11.6.5 Pfizer Recent Development

11.7 Sun Pharmaceuticals

11.7.1 Sun Pharmaceuticals Company Details

11.7.2 Sun Pharmaceuticals Business Overview

11.7.3 Sun Pharmaceuticals Opioid Drugs Introduction

11.7.4 Sun Pharmaceuticals Revenue in Opioid Drugs Business (2020-2025)

11.7.5 Sun Pharmaceuticals Recent Development

11.8 Teva Pharmaceutical Industries Ltd.

11.8.1 Teva Pharmaceutical Industries Ltd. Company Details

11.8.2 Teva Pharmaceutical Industries Ltd. Business Overview

11.8.3 Teva Pharmaceutical Industries Ltd. Opioid Drugs Introduction

11.8.4 Teva Pharmaceutical Industries Ltd. Revenue in Opioid Drugs Business (2020-2025)

11.8.5 Teva Pharmaceutical Industries Ltd. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Acura Pharmaceuticals

Cipher Pharmaceutical Inc.

Daiichi Sankyo

Johnson & Johnson

Lupin Ltd

Pfizer Inc

Sun Pharmaceuticals

Teva Pharmaceutical Industries Ltd

Johnson & Johnson

List of Tables

Table 1. Global Opioid Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Buprenorphine

Table 3. Key Players of Fentanyl

Table 4. Key Players of Hydrocodone

Table 5. Key Players of Morphine

Table 6. Key Players of Oxycodone

Table 7. Key Players of Tramadol

Table 8. Key Players of Others

Table 9. Global Opioid Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 10. Global Opioid Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 11. Global Opioid Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 12. Global Opioid Drugs Market Share by Region (2020-2025)

Table 13. Global Opioid Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 14. Global Opioid Drugs Market Share by Region (2026-2031)

Table 15. Opioid Drugs Market Trends

Table 16. Opioid Drugs Market Drivers

Table 17. Opioid Drugs Market Challenges

Table 18. Opioid Drugs Market Restraints

Table 19. Global Opioid Drugs Revenue by Players (2020-2025) & (US$ Million)

Table 20. Global Opioid Drugs Market Share by Players (2020-2025)

Table 21. Global Top Opioid Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioid Drugs as of 2024)

Table 22. Ranking of Global Top Opioid Drugs Companies by Revenue (US$ Million) in 2024

Table 23. Global 5 Largest Players Market Share by Opioid Drugs Revenue (CR5 and HHI) & (2020-2025)

Table 24. Global Key Players of Opioid Drugs, Headquarters and Area Served

Table 25. Global Key Players of Opioid Drugs, Product and Application

Table 26. Global Key Players of Opioid Drugs, Date of Enter into This Industry

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Opioid Drugs Market Size by Type (2020-2025) & (US$ Million)

Table 29. Global Opioid Drugs Revenue Market Share by Type (2020-2025)

Table 30. Global Opioid Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 31. Global Opioid Drugs Revenue Market Share by Type (2026-2031)

Table 32. Global Opioid Drugs Market Size by Application (2020-2025) & (US$ Million)

Table 33. Global Opioid Drugs Revenue Market Share by Application (2020-2025)

Table 34. Global Opioid Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 35. Global Opioid Drugs Revenue Market Share by Application (2026-2031)

Table 36. North America Opioid Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. North America Opioid Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 38. North America Opioid Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 39. Europe Opioid Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 40. Europe Opioid Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 41. Europe Opioid Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 42. Asia-Pacific Opioid Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 43. Asia-Pacific Opioid Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 44. Asia-Pacific Opioid Drugs Market Size by Region (2026-2031) & (US$ Million)

Table 45. Latin America Opioid Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Latin America Opioid Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 47. Latin America Opioid Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 48. Middle East & Africa Opioid Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 49. Middle East & Africa Opioid Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 50. Middle East & Africa Opioid Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 51. Acura Pharmaceuticals Company Details

Table 52. Acura Pharmaceuticals Business Overview

Table 53. Acura Pharmaceuticals Opioid Drugs Product

Table 54. Acura Pharmaceuticals Revenue in Opioid Drugs Business (2020-2025) & (US$ Million)

Table 55. Acura Pharmaceuticals Recent Development

Table 56. Cipher Pharmaceutical Inc. Company Details

Table 57. Cipher Pharmaceutical Inc. Business Overview

Table 58. Cipher Pharmaceutical Inc. Opioid Drugs Product

Table 59. Cipher Pharmaceutical Inc. Revenue in Opioid Drugs Business (2020-2025) & (US$ Million)

Table 60. Cipher Pharmaceutical Inc. Recent Development

Table 61. Daiichi Sankyo Company Details

Table 62. Daiichi Sankyo Business Overview

Table 63. Daiichi Sankyo Opioid Drugs Product

Table 64. Daiichi Sankyo Revenue in Opioid Drugs Business (2020-2025) & (US$ Million)

Table 65. Daiichi Sankyo Recent Development

Table 66. Johnson＆Johnson Company Details

Table 67. Johnson＆Johnson Business Overview

Table 68. Johnson＆Johnson Opioid Drugs Product

Table 69. Johnson＆Johnson Revenue in Opioid Drugs Business (2020-2025) & (US$ Million)

Table 70. Johnson＆Johnson Recent Development

Table 71. Lupin Limited Company Details

Table 72. Lupin Limited Business Overview

Table 73. Lupin Limited Opioid Drugs Product

Table 74. Lupin Limited Revenue in Opioid Drugs Business (2020-2025) & (US$ Million)

Table 75. Lupin Limited Recent Development

Table 76. Pfizer Company Details

Table 77. Pfizer Business Overview

Table 78. Pfizer Opioid Drugs Product

Table 79. Pfizer Revenue in Opioid Drugs Business (2020-2025) & (US$ Million)

Table 80. Pfizer Recent Development

Table 81. Sun Pharmaceuticals Company Details

Table 82. Sun Pharmaceuticals Business Overview

Table 83. Sun Pharmaceuticals Opioid Drugs Product

Table 84. Sun Pharmaceuticals Revenue in Opioid Drugs Business (2020-2025) & (US$ Million)

Table 85. Sun Pharmaceuticals Recent Development

Table 86. Teva Pharmaceutical Industries Ltd. Company Details

Table 87. Teva Pharmaceutical Industries Ltd. Business Overview

Table 88. Teva Pharmaceutical Industries Ltd. Opioid Drugs Product

Table 89. Teva Pharmaceutical Industries Ltd. Revenue in Opioid Drugs Business (2020-2025) & (US$ Million)

Table 90. Teva Pharmaceutical Industries Ltd. Recent Development

Table 91. Research Programs/Design for This Report

Table 92. Key Data Information from Secondary Sources

Table 93. Key Data Information from Primary Sources

Table 94. Authors List of This Report

List of Figures

Figure 1. Opioid Drugs Picture

Figure 2. Global Opioid Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Opioid Drugs Market Share by Type: 2024 VS 2031

Figure 4. Buprenorphine Features

Figure 5. Fentanyl Features

Figure 6. Hydrocodone Features

Figure 7. Morphine Features

Figure 8. Oxycodone Features

Figure 9. Tramadol Features

Figure 10. Others Features

Figure 11. Global Opioid Drugs Market Size by Application (2020-2031) & (US$ Million)

Figure 12. Global Opioid Drugs Market Share by Application: 2024 VS 2031

Figure 13. Anesthesia Case Studies

Figure 14. Pain relief Case Studies

Figure 15. Cough suppression Case Studies

Figure 16. Diarrhea suppression Case Studies

Figure 17. Deaddiction Case Studies

Figure 18. Others Case Studies

Figure 19. Opioid Drugs Report Years Considered

Figure 20. Global Opioid Drugs Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 21. Global Opioid Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 22. Global Opioid Drugs Market Share by Region: 2024 VS 2031

Figure 23. Global Opioid Drugs Market Share by Players in 2024

Figure 24. Global Top Opioid Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioid Drugs as of 2024)

Figure 25. The Top 10 and 5 Players Market Share by Opioid Drugs Revenue in 2024

Figure 26. North America Opioid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. North America Opioid Drugs Market Share by Country (2020-2031)

Figure 28. United States Opioid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Canada Opioid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Europe Opioid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Europe Opioid Drugs Market Share by Country (2020-2031)

Figure 32. Germany Opioid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. France Opioid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. U.K. Opioid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Italy Opioid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Russia Opioid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Nordic Countries Opioid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Asia-Pacific Opioid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Asia-Pacific Opioid Drugs Market Share by Region (2020-2031)

Figure 40. China Opioid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Japan Opioid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. South Korea Opioid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Southeast Asia Opioid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. India Opioid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Australia Opioid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Latin America Opioid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Latin America Opioid Drugs Market Share by Country (2020-2031)

Figure 48. Mexico Opioid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Brazil Opioid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Middle East & Africa Opioid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Middle East & Africa Opioid Drugs Market Share by Country (2020-2031)

Figure 52. Turkey Opioid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. Saudi Arabia Opioid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 54. UAE Opioid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 55. Acura Pharmaceuticals Revenue Growth Rate in Opioid Drugs Business (2020-2025)

Figure 56. Cipher Pharmaceutical Inc. Revenue Growth Rate in Opioid Drugs Business (2020-2025)

Figure 57. Daiichi Sankyo Revenue Growth Rate in Opioid Drugs Business (2020-2025)

Figure 58. Johnson＆Johnson Revenue Growth Rate in Opioid Drugs Business (2020-2025)

Figure 59. Lupin Limited Revenue Growth Rate in Opioid Drugs Business (2020-2025)

Figure 60. Pfizer Revenue Growth Rate in Opioid Drugs Business (2020-2025)

Figure 61. Sun Pharmaceuticals Revenue Growth Rate in Opioid Drugs Business (2020-2025)

Figure 62. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Opioid Drugs Business (2020-2025)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Opioids Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Narcotic Opioid Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Opioid Induced Side Effects Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Opioid Use Disorder Market Insights Forecast to 2030

Pain Management Product Market

Global Opioid Narcotics Market Research Report 2024

Opioids Agonist Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Synthetic Opioids Market Research Report 2024

Global Opioid Analgesics Market Research Report 2025

Global OTC Pain Medications Market Research Report 2024

Oxycodone Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Drug Abuse Treatment Market Insights Forecast to 2030

Global Lower Back Pain Drug Market Research Report 2025

Global Non Opioid Pain Treatment Market Insights Forecast to 2030

Global Opioid Withdrawal Treatment Market Insights Forecast to 2030

Opioid Withdrawal Management Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Opioid Dependence Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Injectable Pain Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Non Narcotic Analgesics Market Research Report 2025

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-19B19893

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-30B3636

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-3H1702

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-13C3384

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions